global+growth

The delivery comes eight months after the launch of the COVAX initiative, aimed at pooling funds from wealthier countries and non-profits to distribute vaccines equitably around the world.

Video Chat - Streamed live Feb 18th.

Middle-income countries have gained greater access to a variety of needed cardiovascular medicines, but remain unable to close the gap with wealthy nations.

India, the world’s biggest maker of vaccines, has shipped over 17 million vaccine doses to more than two dozen countries - including around 6 million as gifts to partners such as Bangladesh and Nepal.

The sudden rush of announcements was in stark contrast to increasing concerns that COVAX was faltering.

Guinea has recorded four confirmed and four probable cases, including five deaths, in the first resurgence of Ebola since the 2013-2016 outbreak that killed 11,300 people in Guinea, Liberia and Sierra Leone.

The COVAX facility - co-led by the World Health Organization, the GAVI vaccine alliance and others - earlier this month allocated around 330 million doses of COVID-19 vaccines for poorer countries.

The country started rolling out the J&J vaccine in a research study targeting healthcare workers last week and hopes to receive Pfizer doses in the coming months.

The COVID-19 pandemic doesn’t end with a vaccine. It ends when everyone can get one.

The botched COVID-19 vaccination campaign is a great illustration of why our current capitalist system does not work.

The contribution consists of a 300 million euro grant and 200 million euros in guarantees by the European Fund for Sustainable Development plus (EFSD+) that will back a loan by the European Investment Bank.

The 55-member AU hopes to see 60% of the continent’s 1.3 billion people immunised over roughly the next three years.

French President Emmanuel Macron​ called on Thursday for the US​ and European nations to allocate up to 5% of current vaccine​ supplies to developing countries.

Joe Biden will attend his first meeting as U.S. president with Group of Seven leaders on Friday to discuss plans to defeat the novel coronavirus, reopen the battered world economy and counter the challenge posed by China.

Pressure mounts for patent waivers to allow poorer countries to develop their own manufacturing capacity to boost availability.